32 reports

The medical business includes gastrointestinal and respiratory, general surgery, urology/ gynecology, ENT, and medical services.

  • Ear, Nose, And Throat Medicine
  • World
  • Carl Zeiss AG
  • Danaher Corporation
  • Olympus Corporation

MEDICAL BUSINESS INCLUDES GASTROINTESTINAL AND RESPIRATORY, GENERAL SURGERY, UROLOGY/ GYNECOLOGY, ENT AND MEDICAL SERVICE.

  • Ear, Nose, And Throat Medicine
  • World
  • Medtronic, Inc.
  • Olympus Corporation
  • Smith & Nephew Plc

You can easily book an appointment with one online.

  • Ear, Nose, And Throat Medicine
  • World
  • Forecast
  • Natus Medical Incorporated
  • William Demant

NETHERLANDS, ##(##), PP. ##-##.

  • Cancer
  • Ear, Nose, And Throat Medicine
  • Japan
  • United States
  • Forecast

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Ear, Nose, And Throat Medicine
  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • Global head and neck cancer diagnostics market segmentation by method 2014

You can easily book an appointment with one online.

  • Ear, Nose, And Throat Medicine
  • Magnetic Resonance Imaging
  • Respiratory Monitoring
  • GE Healthcare Limited
  • Varian Medical Systems, Inc.

Thus, one cannot turn back.

  • Ear, Nose, And Throat Medicine
  • World
  • Advanced Bionics Corporation
  • Nurotron Biotechnology Co Ltd
  • Sonova Holding AG

Oncology, ##(Suppl ##), ##-## < DOI> ##. ##/ ##< / DOI>.

  • Ear, Nose, And Throat Medicine
  • European Union
  • Japan
  • United States
  • Amgen Inc.
  • Aug 02, 2017: Enzychem Lifesciences's investigational new drug application for chemoradiation induced oral mucositis had been granted by the FDA

Endoscopic data reflect the ability of Brilacidin to help clear Gastrointestinal (GI) tract mucosa in patients suffering from ulcerative colitis.

  • Ear, Nose, And Throat Medicine
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Each warrant will have the right to purchase one-half of one share of its common stock.

  • Ear, Nose, And Throat Medicine
  • Pharmaceutical
  • Therapy
  • United States
  • Soligenix, Inc.

One unit is one oximeter sensor.

  • Respiratory Monitoring
  • Sensor
  • United States
  • Company
  • GlobalData's company
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Merck KG ## ## ## ## ## ## ## C.

  • Cancer
  • Ear, Nose, And Throat Medicine
  • United States
  • World
  • Product Initiative
  • Respiratory Measurement Devices Companies and Product Overview

One unit is one Capnograph.

  • Clinical Trial
  • Drug Discovery And Development
  • Hospital
  • Respiratory Monitoring
  • Sensor
  • 5. All the trials included are unique trials.

Boehringer Sohn AG & Co KG ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## E.

  • Cancer
  • Clinical Trial
  • Ear, Nose, And Throat Medicine
  • World
  • Bristol-Myers Squibb Company

Rice University is investigating WBZ-## for the treatment of gastrointestinal stromal tumor.

  • Ear, Nose, And Throat Medicine
  • Psychotic Disorder
  • Turkey
  • World
  • Product Initiative

It also offers products to treat gastrointestinal disorders, neurodegenerative pathologies and rheumatology diseases.

  • Ear, Nose, And Throat Medicine
  • United States
  • Company
  • Company Financials
  • Otonomy, Inc.

Ignyta, Inc. ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## Merck & Co., Inc. ## ## ## ## ## Loxo Oncology, Inc. ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## F.

  • Chemotherapy
  • Ear, Nose, And Throat Medicine
  • Therapy
  • World
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Ear, Nose, And Throat Medicine
  • Lung Cancer
  • United States
  • World

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Ear, Nose, And Throat Medicine
  • Lung Cancer
  • World

Parion Sciences develops ENaC blockers which are used to treat lung, mouth, nose and the gastrointestinal tract.

  • Clinical Trial
  • Drug Discovery And Development
  • Respiratory Monitoring
  • Therapy
  • United States
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Ear, Nose, And Throat Medicine
  • Oncology
  • United States
  • World

Patients were randomized to receive AM- ## ##. ## mg/ mL, ##. ## mg/ mL or placebo in a ##:##:## ratio.

  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • Therapy
  • United States
  • Product Initiative
  • HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA - PIPELINE BY EISAI CO., LTD., H1 2016
  • HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA - PIPELINE BY HANMI PHARMACEUTICALS, CO. LTD., H1 2016

The most common grade ## or ## adverse events were fatigue and gastrointestinal disturbances, and the most common grade ## or ## adverse events were abdominal pain, hypokalemia and fatigue.

  • Cancer
  • Ear, Nose, And Throat Medicine
  • United States
  • Company
  • Product Initiative
  • CLINICAL TRIAL PROFILE. 1187 TRIAL TITLE
  • CLINICAL TRIAL PROFILE. 46 TRIAL TITLE

Hoffmann-La Roche Ltd. ## ## ## ## ## ## ## ## Merck & Co., Inc. ## ## ## ## ## ## ## ## Bristol-Myers Squibb Company ## ## ## ## ## ## ## ## E.

  • Clinical Trial
  • Drug Discovery And Development
  • Ear, Nose, And Throat Medicine
  • World
  • Product Initiative

Radiation Oncology; ##(##): ##.

  • Ear, Nose, And Throat Medicine
  • Health Services
  • Healthcare
  • Therapy
  • World

Another variant of Passover humidifiers is the wick one.

  • Medical Ventilator
  • Respiratory Monitoring
  • World
  • Forecast
  • Teleflex Incorporated
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Ear, Nose, And Throat Medicine
  • Lung Cancer
  • Therapy
  • World
  • Product Initiative
  • HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA - PIPELINE BY HANMI PHARMACEUTICALS, CO. LTD., H2 2016
  • HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA - PIPELINE BY EISAI CO., LTD., H2 2016

AS OF FEBRUARY 2013, IT WAS IN PHASE II FOR GASTROINTESTINAL STROMAL TUMOR (GIST).

  • Cancer
  • Ear, Nose, And Throat Medicine
  • United States
  • Company
  • Product Initiative

One unit is one PEEP valve.

  • Ear, Nose, And Throat Medicine
  • Respiratory Monitoring
  • North America
  • United States
  • Forecast
  • RECURRENT HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA - PIPELINE BY MEDIMMUNE, LLC, H2 2015
  • RECURRENT HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA - PIPELINE BY ASTRAZENECA PLC, H2 2015

The company also focuses in the infection, neuroscience and gastrointestinal (ING) disease areas.

  • Ear, Nose, And Throat Medicine
  • Hospital
  • United States
  • Company Operations
  • Product Initiative